ECLIPSE PHARMA LTD
Company number 11801370 · Active · London E17 7JH
ECLIPSE PHARMA LTD is an active private limited company (company number 11801370) incorporated on 1 February 2019, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 30 April 2025, showing net assets of £2.88m and cash of £318k, with 10 employees on average. Net assets rose 48% on the prior period (£1.95m).
By net assets it sits in the top quarter of 76 comparable companies in London (median £100, upper quartile £88k).
Key dates
- Incorporated
- 1 February 2019
- Next accounts due
- 30 January 2027 — in 106 days
- Confirmation statement due
- 15 February 2027 — in 122 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 April 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £2.88m | £318k | £720k | £710k | — | — | 10 |
| 30 April 2024 | £1.95m | £557k | £747k | £462k | — | — | 10 |
- Current ratio
- 2.15 — comfortable
- Cash per employee
- £32k
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 88/100 (grade A)
- +10 Positive net assets — Net assets £2,883,042 at 2025-04-30
- +8 Net assets growing — +47.8% vs prior period
- +8 Comfortable liquidity — Current ratio 2.15
- +4 Cash reserves — Cash £318,329
- +8 Established — Incorporated 2019-02-01 (8 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Mohammed Umar Mahmood — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 1 February 2019
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (manufacture of pharmaceutical preparations), closest in incorporation date.
- CELADON PHARMA HOLD CO LTD — London, inc. Jan 2019
- INFIRST LIMITED — London, inc. Feb 2019
- GENETIS LIMITED — London, inc. Dec 2018
- NAOTA KABAF GLOBAL VENTURES LTD — London, inc. Apr 2019
- SPF EXPERT LTD — London, inc. Oct 2018
- CELADON PHARMA LTD — London, inc. Sept 2018
Reminders for ECLIPSE PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.